Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
4.950
+0.030 (0.61%)
At close: Feb 13, 2026, 4:00 PM EST
4.960
+0.010 (0.20%)
After-hours: Feb 13, 2026, 4:54 PM EST
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $9.5 million as of February 13, 2026. Its market cap has decreased by -50.64% in one year.
Market Cap
9.50M
Enterprise Value
1.18M
1-Year Change
-50.64%
Ranking
Category
Stock Price
$4.95
Market Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $9.50M, a decrease of -98.62%. That is a compound annual growth rate of -57.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 9.50M | -9.47% |
| Dec 31, 2025 | 10.50M | -48.75% |
| Dec 31, 2024 | 20.48M | -51.84% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CollPlant Biotechnologies | 10.37M |
| GridAI Technologies | 10.29M |
| Liminatus Pharma | 10.18M |
| BiomX | 9.77M |
| BioVie | 9.58M |
| CalciMedica | 9.44M |
| Chemomab Therapeutics | 9.29M |
| Pulmatrix | 8.89M |